NAPROXEN
- Product NDC
- 42708-140
- 11-digit product format
- 427080140
- Labeler code
- 42708
- Product ID
- 42708-140_459bfcc2-12bd-82a9-e063-6294a90a6ca3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- QPharma Inc
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2016-07-06
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NAPROXEN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NAPROXEN | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 57Y76R9ATQ |
| Rxcui | 198014 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-140-20 | NAPROXEN | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-140 | NAPROXEN TABLET [QPHARMA INC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241123_c0a4839b-7154-c82c-e053-2a95a90a7e6d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42708-140-20 | 42708014020 | 20 TABLET in 1 BOTTLE, PLASTIC (42708-140-20) | 20 tablet | 2021-04-23 | 0000-00-00 | Yes | No | Current |